Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 1987-06-01 (38 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: OLLIOULES (83190), Var
SELAS PHARMACIE SAINT-LAURENT : revenue, balance sheet and financial ratios
SELAS PHARMACIE SAINT-LAURENT is a French company
founded 38 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in OLLIOULES (83190),
this company of category PME
shows in 2022 a revenue of 1.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE SAINT-LAURENT (SIREN 341654523)
Indicator
2024
2023
2022
2020
2019
2018
2017
Revenue
N/C
N/C
1 513 643 €
1 370 453 €
1 296 745 €
1 265 983 €
1 326 773 €
Net income
121 555 €
174 147 €
150 268 €
40 796 €
9 310 €
25 376 €
37 388 €
EBITDA
N/C
N/C
206 170 €
102 586 €
83 743 €
92 678 €
112 015 €
Net margin
N/C
N/C
9.9%
3.0%
0.7%
2.0%
2.8%
Revenue and income statement
In 2024, SELAS PHARMACIE SAINT-LAURENT generates positive net income of 122 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 37 k€ -> 122 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
121 555 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 10%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 77%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
10.48%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
77.485%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2022
2023
2024
Debt ratio
5.833
4.935
5.748
4.348
13.078
11.426
10.48
Financial autonomy
84.79
83.513
78.978
83.161
73.641
75.14
77.485
Repayment capacity
1.08
1.354
7.337
0.952
0.745
None
None
Cash flow / Revenue
3.068%
2.128%
0.428%
2.498%
10.554%
None%
None%
Sector positioning
Debt ratio
10.482024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of SELAS PHARMACIE SAINT-LAU... (10.48) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
77.48%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+5 pts over 3 years
In 2024, the financial autonomy of SELAS PHARMACIE SAINT-LAU... (77.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.74 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of SELAS PHARMACIE SAINT-LAU... (0.74) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 313.16. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2022
2023
2024
Liquidity ratio
288.567
239.168
179.997
220.613
244.437
266.443
313.163
Interest coverage
0.153
0.093
0.068
0.058
0.932
None
None
Sector positioning
Liquidity ratio
313.162024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent+10 pts over 3 years
In 2024, the liquidity ratio of SELAS PHARMACIE SAINT-LAU... (313.16) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.93x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of SELAS PHARMACIE SAINT-LAU... (0.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELAS PHARMACIE SAINT-LAURENT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2022
2023
2024
Operating WCR
99 229 €
78 200 €
40 770 €
104 031 €
245 710 €
0 €
0 €
Inventory turnover (days)
23
27
26
26
44
0
0
Customer payment term (days)
4
1
1
3
3
0
0
Supplier payment term (days)
19
17
18
25
52
0
0
Positioning of SELAS PHARMACIE SAINT-LAURENT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELAS PHARMACIE SAINT-LAURENT is estimated at
1 696 997 €
(range 1 181 762€ - 2 538 805€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1181k€1696k€2538k€
1 696 997 €Range: 1 181 762€ - 2 538 805€
NAF 5 année 2024
Valuation method used
Net Income Multiple
121 555 €
×
14.0x
=1 696 998 €
Range: 1 181 762€ - 2 538 806€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE SAINT-LAURENT with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE SAINT-LAURENT
What is the revenue of SELAS PHARMACIE SAINT-LAURENT ?
The revenue of SELAS PHARMACIE SAINT-LAURENT in 2022 is 1.5 M€.
Is SELAS PHARMACIE SAINT-LAURENT profitable?
Yes, SELAS PHARMACIE SAINT-LAURENT generated a net profit of 122 k€ in 2024.
Where is the headquarters of SELAS PHARMACIE SAINT-LAURENT ?
The headquarters of SELAS PHARMACIE SAINT-LAURENT is located in OLLIOULES (83190), in the department Var.
Where to find the tax return of SELAS PHARMACIE SAINT-LAURENT ?
The tax return of SELAS PHARMACIE SAINT-LAURENT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE SAINT-LAURENT operate?
SELAS PHARMACIE SAINT-LAURENT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart